Stay updated with breaking news from Stabilization Technologies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
BlueRiver Acquisition Corp. announces that, as disclosed in the Company’s Current Report on Form 8-K filed on February 7, 2024 with the United States Securities and Exchange Commission, the...
Spinal Stabilization Technologies is a pioneer in developing minimally invasive surgical treatments for specific types of lower back pain. It is targeting a promising market opportunity within the...
Spinal Stabilization Technologies and BlueRiver Acquisition entered into a definitive business combination agreement, according to a July 24 news release.
/PRNewswire/ -- Spinal Stabilization Technologies (SST) has announced the start of the LOPAIN2 clinical trial of the PerQdisc™ Nucleus Replacement Device (NRD)....
This article examines the need to conduct medtech clinical trials outside the U.S. and explores the growth of these trials in Latin America,...